{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:45:02Z","timestamp":1793371502291,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04156-6","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:45:21Z","timestamp":1782153921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["taVNS alleviates depressive-like and metabolic dysfunction in T2DD mice with modulation of hypothalamic 5-HT signaling"],"prefix":"10.1038","volume":"16","author":[{"given":"Yuzhengheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7288-2319","authenticated-orcid":false,"given":"Peijing","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5743-6273","authenticated-orcid":false,"given":"Shaoyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"4156_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00592-019-01295-9","volume":"56","author":"M Khaledi","year":"2019","unstructured":"Khaledi M, Haghighatdoost F, Feizi A, Aminorroaya A. The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetol. 2019;56:631\u201350.","journal-title":"Acta Diabetol"},{"key":"4156_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.861110","volume":"9","author":"M Zhu","year":"2022","unstructured":"Zhu M, Li Y, Luo B, Cui J, Liu Y, Liu Y. Comorbidity of type 2 diabetes mellitus and depression: clinical evidence and rationale for the exacerbation of cardiovascular disease. Front Cardiovasc Med. 2022;9:861110.","journal-title":"Front Cardiovasc Med"},{"key":"4156_CR3","first-page":"160","volume":"39","author":"AF Milano","year":"2007","unstructured":"Milano AF, Singer RB. Mortality in co-morbidity (II)-excess death rates derived from a follow-up study on 10,025 subjects divided into 4 groups with or without depression and diabetes mellitus. J Insur Med. 2007;39:160\u20136.","journal-title":"J Insur Med"},{"key":"4156_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03234-5","volume":"15","author":"G Fanelli","year":"2025","unstructured":"Fanelli G, Raschi E, Hafez G, Matura S, Schiweck C, Poluzzi E, et al. The interface of depression and diabetes: treatment considerations. Transl Psychiatry. 2025;15:22.","journal-title":"Transl Psychiatry"},{"key":"4156_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fpsyt.2018.00020","volume":"9","author":"J Kong","year":"2018","unstructured":"Kong J, Fang J, Park J, Li S, Rong P. Treating depression with transcutaneous auricular vagus nerve stimulation: state of the art and future perspectives. Front Psychiatry. 2018;9:20.","journal-title":"Front Psychiatry"},{"key":"4156_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jad.2016.02.031","volume":"195","author":"P Rong","year":"2016","unstructured":"Rong P, Liu J, Wang L, Liu R, Fang J, Zhao J, et al. Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: a nonrandomized controlled pilot study. J Affect Disord. 2016;195:172\u20139.","journal-title":"J Affect Disord"},{"key":"4156_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.neurom.2021.10.021","volume":"25","author":"S Li","year":"2022","unstructured":"Li S, Rong P, Wang Y, Jin G, Hou X, Li S, et al. Comparative effectiveness of transcutaneous auricular vagus nerve stimulation vs citalopram for major depressive disorder: a randomized trial. Neuromodulation. 2022;25:450\u201360.","journal-title":"Neuromodulation"},{"key":"4156_CR8","doi-asserted-by":"publisher","first-page":"e2451217","DOI":"10.1001\/jamanetworkopen.2024.51217","volume":"7","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhao Y, Qin Z, Han Y, He J, Zhao B, et al. Transcutaneous auricular vagus nerve stimulation for chronic insomnia disorder: a randomized clinical trial. JAMA Netw Open. 2024;7:e2451217.","journal-title":"JAMA Netw Open"},{"key":"4156_CR9","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15253","volume":"10","author":"EM Kozorosky","year":"2022","unstructured":"Kozorosky EM, Lee CH, Lee JG, Nunez Martinez V, Padayachee LE, Stauss HM. Transcutaneous auricular vagus nerve stimulation augments postprandial inhibition of ghrelin. Physiol Rep. 2022;10:e15253.","journal-title":"Physiol Rep"},{"key":"4156_CR10","doi-asserted-by":"publisher","first-page":"e111100","DOI":"10.1371\/journal.pone.0111100","volume":"9","author":"S Li","year":"2014","unstructured":"Li S, Zhai X, Rong P, McCabe MF, Zhao J, Ben H, et al. Transcutaneous auricular vagus nerve stimulation triggers melatonin secretion and is antidepressive in Zucker diabetic fatty rats. PLoS One. 2014;9:e111100.","journal-title":"PLoS One"},{"key":"4156_CR11","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3390\/ijms23031600","volume":"23","author":"K Nonogaki","year":"2022","unstructured":"Nonogaki K. The regulatory role of the central and peripheral serotonin network on feeding signals in metabolic diseases. Int J Mol Sci. 2022;23:1600.","journal-title":"Int J Mol Sci"},{"key":"4156_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuron.2006.06.004","volume":"51","author":"LK Heisler","year":"2006","unstructured":"Heisler LK, Jobst EE, Sutton GM, Zhou L, Borok E, Thornton-Jones Z, et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron. 2006;51:239\u201349.","journal-title":"Neuron"},{"key":"4156_CR13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.neuron.2008.09.033","volume":"60","author":"Y Xu","year":"2008","unstructured":"Xu Y, Jones JE, Kohno D, Williams KW, Lee CE, Choi MJ, et al. 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron. 2008;60:582\u20139.","journal-title":"Neuron"},{"key":"4156_CR14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.cmet.2007.10.008","volume":"6","author":"L Zhou","year":"2007","unstructured":"Zhou L, Sutton GM, Rochford JJ, Semple RK, Lam DD, Oksanen LJ, et al. Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab. 2007;6:398\u2013405.","journal-title":"Cell Metab"},{"key":"4156_CR15","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1038\/s41380-023-02095-y","volume":"28","author":"S Jauhar","year":"2023","unstructured":"Jauhar S, Arnone D, Baldwin DS, Bloomfield M, Browning M, Cleare AJ, et al. A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression. Mol Psychiatry. 2023;28:3149\u201352.","journal-title":"Mol Psychiatry"},{"key":"4156_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0253-7613.150305","volume":"47","author":"V Prabhakar","year":"2015","unstructured":"Prabhakar V, Gupta D, Kanade P, Radhakrishnan M. Diabetes-associated depression: the serotonergic system as a novel multifunctional target. Indian J Pharmacol. 2015;47:4\u201310.","journal-title":"Indian J Pharmacol"},{"key":"4156_CR17","doi-asserted-by":"publisher","first-page":"e112066","DOI":"10.1371\/journal.pone.0112066","volume":"9","author":"S Li","year":"2014","unstructured":"Li S, Zhai X, Rong P, McCabe MF, Wang X, Zhao J, et al. Therapeutic effect of vagus nerve stimulation on depressive-like behavior, hyperglycemia and insulin receptor expression in Zucker fatty rats. PLoS One. 2014;9:e112066.","journal-title":"PLoS One"},{"key":"4156_CR18","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1111\/cns.14207","volume":"29","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhang Y, Wang J, Li S, Wang Y, Zhang Z, et al. Anti-neuroinflammation effects of transcutaneous auricular vagus nerve stimulation against depression-like behaviors via hypothalamic \u03b17nAchR\/JAK2\/STAT3\/NF-\u03baB pathway in rats exposed to chronic unpredictable mild stress. CNS Neurosci Ther. 2023;29:2634\u201344.","journal-title":"CNS Neurosci Ther"},{"key":"4156_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","volume":"83","author":"RN Walsh","year":"1976","unstructured":"Walsh RN, Cummins RA. The open-field test: a critical review. Psychol Bull. 1976;83:482\u2013504.","journal-title":"Psychol Bull"},{"key":"4156_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463:3\u201333.","journal-title":"Eur J Pharmacol"},{"key":"4156_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41592-024-02188-8","volume":"21","author":"F Deng","year":"2024","unstructured":"Deng F, Wan J, Li G, Dong H, Xia X, Wang Y, et al. Improved green and red GRAB sensors for monitoring spatiotemporal serotonin release in vivo. Nat Methods. 2024;21:692\u2013702.","journal-title":"Nat Methods"},{"key":"4156_CR22","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1364\/BOE.10.004075","volume":"10","author":"T Zheng","year":"2019","unstructured":"Zheng T, Feng Z, Wang X, Jiang T, Jin R, Zhao P, et al. Review of micro-optical sectioning tomography (MOST): technology and applications for whole-brain optical imaging [Invited]. Biomed Opt Express. 2019;10:4075\u201396.","journal-title":"Biomed Opt Express"},{"key":"4156_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.neubiorev.2005.01.004","volume":"29","author":"DA Groves","year":"2005","unstructured":"Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that link to its clinical effects. Neurosci Biobehav Rev. 2005;29:493\u2013500.","journal-title":"Neurosci Biobehav Rev"},{"key":"4156_CR24","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.brs.2014.11.018","volume":"8","author":"E Frangos","year":"2015","unstructured":"Frangos E, Ellrich J, Komisaruk BR. Non-invasive access to the vagus nerve central projections via electrical stimulation of the external ear: fMRI evidence in humans. Brain Stimul. 2015;8:624\u201336.","journal-title":"Brain Stimul"},{"key":"4156_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/nmo.12076","volume":"25","author":"B Bonaz","year":"2013","unstructured":"Bonaz B, Picq C, Sinniger V, Mayol JF, Claren\u00e7on D. Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil. 2013;25:208\u201321.","journal-title":"Neurogastroenterol Motil"},{"key":"4156_CR26","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.brs.2013.01.011","volume":"6","author":"T Kraus","year":"2013","unstructured":"Kraus T, Kiess O, H\u00f6sl K, Terekhin P, Kornhuber J, Forster C. CNS BOLD fMRI effects of sham-controlled transcutaneous electrical nerve stimulation in the left outer auditory canal - a pilot study. Brain Stimul. 2013;6:798\u2013804.","journal-title":"Brain Stimul"},{"key":"4156_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.physbeh.2010.07.002","volume":"101","author":"AN Sharma","year":"2010","unstructured":"Sharma AN, Elased KM, Garrett TL, Lucot JB. Neurobehavioral deficits in db\/db diabetic mice. Physiol Behav. 2010;101:381\u20138.","journal-title":"Physiol Behav"},{"key":"4156_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12263-015-0458-2","volume":"10","author":"M Razzoli","year":"2015","unstructured":"Razzoli M, McCallum J, Gurney A, Engeland WC, Bartolomucci A. Chronic stress aggravates glucose intolerance in leptin receptor-deficient (db\/db) mice. Genes Nutr. 2015;10:458.","journal-title":"Genes Nutr"},{"key":"4156_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3389\/fnins.2020.00680","volume":"14","author":"S Li","year":"2020","unstructured":"Li S, Wang Y, Gao G, Guo X, Zhang Y, Zhang Z, et al. Transcutaneous auricular vagus nerve stimulation at 20 Hz improves depression-like behaviors and down-regulates the hyperactivity of HPA axis in chronic unpredictable mild stress model rats. Front Neurosci. 2020;14:680.","journal-title":"Front Neurosci"},{"key":"4156_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nicl.2016.12.016","volume":"14","author":"J Fang","year":"2016","unstructured":"Fang J, Egorova N, Rong P, Liu J, Hong Y, Fan Y, et al. Early cortical biomarkers of longitudinal transcutaneous vagus nerve stimulation treatment success in depression. Neuroimage Clin. 2016;14:105\u201311.","journal-title":"Neuroimage Clin"},{"key":"4156_CR31","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41380-022-01812-3","volume":"29","author":"H Martin","year":"2024","unstructured":"Martin H, Bullich S, Martinat M, Chataigner M, Di Miceli M, Simon V, et al. Insulin modulates emotional behavior through a serotonin-dependent mechanism. Mol Psychiatry. 2024;29:1610\u20139.","journal-title":"Mol Psychiatry"},{"key":"4156_CR32","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.brs.2017.12.009","volume":"11","author":"BW Badran","year":"2018","unstructured":"Badran BW, Dowdle LT, Mithoefer OJ, LaBate NT, Coatsworth J, Brown JC, et al. Neurophysiologic effects of transcutaneous auricular vagus nerve stimulation (taVNS) via electrical stimulation of the tragus: a concurrent taVNS\/fMRI study and review. Brain Stimul. 2018;11:492\u2013500.","journal-title":"Brain Stimul"},{"key":"4156_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s12276-021-00597-9","volume":"53","author":"ES Yoo","year":"2021","unstructured":"Yoo ES, Yu J, Sohn JW. Neuroendocrine control of appetite and metabolism. Exp Mol Med. 2021;53:505\u201316.","journal-title":"Exp Mol Med"},{"key":"4156_CR34","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/brainsci11101298","volume":"11","author":"J Mikulska","year":"2021","unstructured":"Mikulska J, Juszczyk G, Gawro\u0144ska-Grzywacz M, Herbet M. HPA axis in the pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation. Brain Sci. 2021;11:1298.","journal-title":"Brain Sci"},{"key":"4156_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108877","volume":"203","author":"JM Erichsen","year":"2022","unstructured":"Erichsen JM, Fadel JR, Reagan LP. Peripheral versus central insulin and leptin resistance: role in metabolic disorders, cognition, and neuropsychiatric diseases. Neuropharmacology. 2022;203:108877.","journal-title":"Neuropharmacology"},{"key":"4156_CR36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.biopsych.2015.03.025","volume":"79","author":"J Fang","year":"2016","unstructured":"Fang J, Rong P, Hong Y, Fan Y, Liu J, Wang H, et al. Transcutaneous vagus nerve stimulation modulates default mode network in major depressive disorder. Biol Psychiatry. 2016;79:266\u201373.","journal-title":"Biol Psychiatry"},{"key":"4156_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jad.2016.08.003","volume":"205","author":"J Liu","year":"2016","unstructured":"Liu J, Fang J, Wang Z, Rong P, Hong Y, Fan Y, et al. Transcutaneous vagus nerve stimulation modulates amygdala functional connectivity in patients with depression. J Affect Disord. 2016;205:319\u201326.","journal-title":"J Affect Disord"},{"key":"4156_CR38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.brs.2015.11.003","volume":"9","author":"S Bauer","year":"2016","unstructured":"Bauer S, Baier H, Baumgartner C, Bohlmann K, Fauser S, Graf W, et al. Transcutaneous vagus nerve stimulation (tVNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial (cMPsE02). Brain Stimul. 2016;9:356\u201363.","journal-title":"Brain Stimul"},{"key":"4156_CR39","doi-asserted-by":"publisher","unstructured":"Badran BW, Yu AB, Adair D, Mappin G, DeVries WH, Jenkins DD, et al. Laboratory administration of transcutaneous auricular vagus nerve stimulation (taVNS): technique, targeting, and considerations. J Vis Exp. 2019;:https:\/\/doi.org\/10.3791\/58984.","DOI":"10.3791\/58984"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04156-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:01:27Z","timestamp":1788397287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04156-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4156"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04156-6","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The experimental protocol was approved by the Ethics Committee of the Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (Approval No. Y2024-03-11-03). All procedures conformed to the \u201cGuidelines on the Humane Treatment of Laboratory Animals\u201d and the \u201cGuidelines for Ethical Review of Laboratory Animal Welfare\u201d (GB\/T 35892-2018).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"446"}}